Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Tumor Polypeptide DC-CTL in the Treatment of Solid Tumors

NCT06524024 is registered in ClinicalTrials.gov with Zhengzhou Revo-Gene Technology Co., LTD as lead sponsor.

NCT NCT06524024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06524024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Tumor Polypeptide DC-CTL in the Treatment of Solid Tumors
Lead sponsor
Zhengzhou Revo-Gene Technology Co., LTD
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
April 1, 2027
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor